Cardinal Health, Inc.
CAH
株式のランク
#400
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
株価
$257.03
最終同期: 2026-10-20
時価総額
$59.52B
変化（1日）
1.57%
変化（1年）
61.98%
国
US
取引 Cardinal Health, Inc. (CAH)
カテゴリー
Healthcare
Cardinal Health, Inc.（CAH）の収益
Jun 2026 時点の収益 TTM: $254.25B
Cardinal Health, Inc. の最新の財務報告によると、現在の収益 (TTM) は $254.25B です。2024 年には $226.83B の収益があり、これは 2023 年の $204.98B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Cardinal Health, Inc. の収益履歴（2000 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $254.25B | 14.23% |
| 2025 | $222.58B | -1.87% |
| 2024 | $226.83B | 10.66% |
| 2023 | $204.98B | 13.04% |
| 2022 | $181.33B | 11.61% |
| 2021 | $162.47B | 6.24% |
| 2020 | $152.92B | 5.08% |
| 2019 | $145.53B | 6.38% |
| 2018 | $136.81B | 5.26% |
| 2017 | $129.98B | 6.94% |
| 2016 | $121.55B | 18.55% |
| 2015 | $102.53B | 12.57% |
| 2014 | $91.08B | -9.90% |
| 2013 | $101.09B | -6.01% |
| 2012 | $107.55B | 4.78% |
| 2011 | $102.64B | 4.20% |
| 2010 | $98.50B | 2.62% |
| 2009 | $95.99B | 9.82% |
| 2008 | $87.41B | 0.64% |
| 2007 | $86.85B | 9.02% |
| 2006 | $79.66B | 9.63% |
| 2005 | $72.67B | 12.62% |
| 2004 | $64.52B | 13.73% |
| 2003 | $56.73B | 10.94% |
| 2002 | $51.14B | 6.65% |
| 2001 | $47.95B | 25.03% |
| 2000 | $38.35B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $410.98B | 61.65% |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| $7.64B | -96.99% |
AU
|
|
| $13.60B | -94.65% |
US
|
